Control of microglial neurotoxicity by the fractalkine receptor
The DOI matches its Crossref record; 38 of the 39 references it cites were found in a registry or an index.
Abstract
Microglia, the resident inflammatory cells of the CNS, are the only CNS cells that express the fractalkine receptor (CX3CR1). Using three different in vivo models, we show that CX3CR1 deficiency dysregulates microglial responses, resulting in neurotoxicity. Following peripheral lipopolysaccharide injections, Cx3cr1-/- mice showed cell-autonomous microglial neurotoxicity. In a toxic model of Parkinson disease and a transgenic model of amyotrophic lateral sclerosis, Cx3cr1-/- mice showed more extensive neuronal cell loss than Cx3cr1+ littermate controls. Augmenting CX3CR1 signaling may protect against microglial neurotoxicity, whereas CNS penetration by pharmaceutical CX3CR1 antagonists could increase neuronal vulnerability.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Microglia were labeled using the CX3CR1+/GFP mouse line in which all microglia express EGFP under the control of fractalkine receptor, CX3CR1, expression (Figure 1, S1, and S5) (Cardona et al., 2006; Jung et al., 2000; Saederup et al., 2010).”
From Microglia Sculpt Postnatal Neural Circuits in an Activity and Complement-Dependent Manner (2012) · cites this paper as Cardona et al., 2006
In the citing paper
“microglia are uniformly CX3CR1+ from early embryonic time points through adulthood (Cardona et al., 2006; Ginhoux et al., 2010; Schulz et al., 2012)”
From Differential roles of microglia and monocytes in the inflamed central nervous system (2014) · cites this paper as Cardona et al., 2006
In the citing paper
“Conflicting evidence in the literature suggests either neurotoxic or neuroprotective effects of CX3CR1 deletion in various disease models (Cardona et al., 2006; Fuhrmann et al., 2010).”
From CX3CR1 in Microglia Regulates Brain Amyloid Deposition through Selective Protofibrillar Amyloid-β Phagocytosis (2010) · cites this paper as Cardona et al., 2006
In the citing paper
“Our findings support the concept that fractalkine through its receptor CX3CR1 (Harrison et al., 1998) acts as a repressor of microglia activation (Cardona et al., 2006).”
From CX3CR1 in Microglia Regulates Brain Amyloid Deposition through Selective Protofibrillar Amyloid-β Phagocytosis (2010) · cites this paper as Cardona et al., 2006
In the citing paper
“While CX3CR1 is expressed by many leukocyte cell types in the periphery, 15 in the brain CX3CR1 is exclusively expressed by microglia 13 whereas CX3CL1 is highly expressed within neurons.14”
From CX3CR1 Deficiency Alters Microglial Activation and Reduces Beta-Amyloid Deposition in Two Alzheimer's Disease Mouse Models (2010) · cites this paper as [13]
15 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo
Nimmerjahn, A., Kirchhoff, F., & Helmchen, F. (2005) · Science · doi:10.1126/science.1110647 · Cited by 5,827 · cited 1×
“Microglia, which have characteristics of immature myeloid cells, sample the extracellular space of the healthy CNS through continuous extension, retraction and remodeling of cellular processe”
BackgroundMicroglia: a sensor for pathological events in the CNS
Kreutzberg, G. W. (1996) · Trends in Neurosciences · doi:10.1016/0166-2236(96)10049-7 · Cited by 4,396 · cited 1×
“In response to injury, microglial cells undergo rapid morphological and functional activation and acquire properties of mature myeloid cells, including antigen presentation, reactive species generation, matrix metalloproteinase (MMP) expression and phagocytosis, as well as cytokine and growth factor secretio”
BackgroundATP mediates rapid microglial response to local brain injury in vivo
Davalos, D., Grutzendler, J., Yang, G., Kim, J. V., Zuo, Y., Jung, S., Littman, D. R., Dustin, M. L., & Gan, W.-B. (2005) · Nature Neuroscience · doi:10.1038/nn1472 · Cited by 3,913 · cited 1×
“Microglia, which have characteristics of immature myeloid cells, sample the extracellular space of the healthy CNS through continuous extension, retraction and remodeling of cellular processe”
BackgroundSelf-citationBlood Monocytes Consist of Two Principal Subsets with Distinct Migratory Properties
Geissmann, F., Jung, S., & Littman, D. R. (2003) · Immunity · doi:10.1016/s1074-7613(03)00174-2 · Cited by 3,391 · cited 1×
“However, peripheral immune and inflammatory reactions are mostly unaltered in Cx3cr1 −/− or Cx3cl1 −/− mic”
BackgroundSelf-citationJung, S., Aliberti, J., Graemmel, P., Sunshine, M. J., Kreutzberg, G. W., Sher, A., & Littman, D. R. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.11.4106-4114.2000 · Cited by 2,632
Self-citationThe many roles of chemokines and chemokine receptors in inflammation
Charo, I. F., & Ransohoff, R. M. (2006) · New England Journal of Medicine · doi:10.1056/nejmra052723 · Cited by 2,523 · cited 1×
“Based on these and other findings, efforts to develop pharmacological inhibitors of CX3CR1 are in progres”
BackgroundSelf-citationCX 3 CR1-Mediated Dendritic Cell Access to the Intestinal Lumen and Bacterial Clearance
Niess, J. H., Brand, S., Gu, X., Landsman, L., Jung, S., McCormick, B. A., Vyas, J. M., Boes, M., Ploegh, H. L., Fox, J. G., et al. (2005) · Science · doi:10.1126/science.1102901 · Cited by 1,611 · cited 2×
“Targeted deletion of CX(3)CR1 reveals a role for fractalkine in cardiac allograft rejection.”
BackgroundSelf-citationMicroglia-specific localisation of a novel calcium binding protein, Iba1
Ito, D., Imai, Y., Ohsawa, K., Nakajima, K., Fukuuchi, Y., & Kohsaka, S. (1998) · Molecular Brain Research · doi:10.1016/s0169-328x(98)00040-0 · Cited by 1,476 · cited 1×
“Results Neuronal damage in Cx3cr1 −/− mice after systemic LPS We first examined the GFP + population in the CNS of Cx3cr1 GFP mice and found that green fluorescent cells overlapped precisely with brain cells expressing microglial markers such as ionized calcium-binding adapter molecule-1 (IBA-1”
BackgroundHarrison, J. K., Jiang, Y., Chen, S., Xia, Y., Maciejewski, D., McNamara, R. K., Streit, W. J., Salafranca, M. N., Adhikari, S., Thompson, D. A., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.18.10896 · Cited by 1,176 · cited 1×
“dtd" [ ]> CX3CR1 is expressed by monocytes, dendritic cells (DCs), and subsets of T cells and natural killer cells in the circulation and by microglia in the central nervous system (CNS”
Takahashi, K., Rochford, C. D. P., & Neumann, H. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041611 · Cited by 1,124 · cited 1×
“Knockdown of TREM2 in mouse microglia impairs their phagocytic activity and enhances inflammatory gene expression, suggesting a mechanism for the human disorde”
Background
Cited by
Items 501–600 of 1,003
Ertürk, A., Mentz, S., Stout, E. E., Hedehus, M., Dominguez, S. L., Neumaier, L., Krammer, F., Llovera, G., Srinivasan, K., Hansen, D. V., et al. (2016) · The Journal of Neuroscience · doi:10.1523/jneurosci.1898-15.2016 · Cited by 89
“Interestingly, homozygous deletion of CX3CR1 dysregulates the microglial response and results in more neurotoxicity in Parkinson’s disease and amyotrophic lateral sclerosis mouse models (Cardona et al., 2006), suggesting that a complete lack of CX3CR1 can aggravate neurodegeneration rather than being more neuroprotect…”
BackgroundJiang, T., Zhang, L., Pan, X., Zheng, H., Chen, X., Li, L., Luo, J., & Hu, X. (2017) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2017.00404 · Cited by 88
“The CX3CL1/CX3CR1 axis, an important signaling pathway in regulating microglia activation, plays a role in maintaining microglia in a resting state and suppressing the neurotoxic effect of activated microglia (Cardona et al., 2006; Ransohoff and El Khoury, 2015).”
Fractalkine/CX3CR1 is involved in the cross-talk between neuron and glia in neurological diseases
Luo, P., Chu, S.-F., Zhang, Z., Xia, C.-Y., & Chen, N.-H. (2019) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2018.11.017 · Cited by 89
Peña-Philippides, J. C., Yang, Y., Bragina, O. A., Hagberg, S., Nemoto, E. M., & Roitbak, T. (2014) · Translational Stroke Research · doi:10.1007/s12975-014-0334-1 · Cited by 98
“62 Chemokine (C-X3-C motif) ligand 1 (promotes neuronal survival and inhibits microglial apoptosis) [26]”
Defining the Microglia Response during the Time Course of Chronic Neurodegeneration
Vincenti, J. E., Murphy, L., Grabert, K., McColl, B. W., Cancellotti, E., Freeman, T. C., & Manson, J. C. (2016) · Journal of Virology · doi:10.1128/jvi.02613-15 · Cited by 88
“5 cells contribute to the activated ‘profile’ adopted by microglia with signalling from both 70 astrocytes and neurons having particular impact (23-26).”
Wlodarczyk, A., Cédile, O., Jensen, K. N., Jasson, A., Mony, J. T., Khorooshi, R., & Owens, T. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00463 · Cited by 88
“Disruption of CX3CR1–CX3CL1 axis leads to microglial activation and hypersensitivity and may result in neurotoxicity [(18) and reviewed in Ref.”
BackgroundResultLiu, W., Jiang, L., Bian, C., Liang, Y., Xing, R., Yishakea, M., & Dong, J. (2016) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-016-0395-9 · Cited by 102
Attenuation of CNS inflammatory responses by nicotine involves α7 and non-α7 nicotinic receptors
Hao, J., Simard, A. R., Turner, G. H., Wu, J., Whiteaker, P., Lukas, R. J., & Shi, F. (2010) · Experimental Neurology · doi:10.1016/j.expneurol.2010.09.020 · Cited by 95
Role of microglia-neuron interactions in diabetic encephalopathy
Liu, Y., Li, M., Zhang, Z., Ye, Y., & Zhou, J. (2017) · Ageing Research Reviews · doi:10.1016/j.arr.2017.12.005 · Cited by 90
Belarbi, K., Arellano, C., Ferguson, R., Jopson, T., & Rosi, S. (2012) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2011.07.225 · Cited by 87
Melief, J., de Wit, S. J., van Eden, C. G., Teunissen, C. E., Hamann, J., Uitdehaag, B. M. J., Swaab, D. F., & Huitinga, I. (2013) · Acta Neuropathologica · doi:10.1007/s00401-013-1140-7 · Cited by 91
“The NAWM of MS patients with high cortisol levels also had decreased mRNA levels of the inflammatory chemokine CX3CL1 and its neuroprotective receptor CX3CR1, which are both negatively regulated by glucocorticoids and play an important role in neuroinflammation by promoting leukocyte recruitment from the periphery and…”
Linnartz, B., Wang, Y., & Neumann, H. (2010) · International Journal of Alzheimer's Disease · doi:10.4061/2010/587463 · Cited by 87
“On the other hand, they can also initiate antiinflammatory and immunosuppressive signaling that results in repair, resolution of inflammation and turning back to tissue homeostasis [3, 6, 7].”
Fractalkine/CX3CR1 Signalling in Chronic Pain and Inflammation
Clark, A. K., Staniland, A. A., & Malcangio, M. (2011) · Current Pharmaceutical Biotechnology · doi:10.2174/138920111798357465 · Cited by 90
“This CX3CR1-p38 MAPK pro-inflammatory cytokine pathway is alternative to signalling of CX3CR1 via phosphatidylinositol 3-kinase (PI3K), which results in reduction of pro-inflammatory cytokine production and mediates the neuroprotective effects of FKN [26].”
BackgroundRegulation of Adaptive Immunity by the Fractalkine Receptor during Autoimmune Inflammation
Garcia, J. A., Pino, P. A., Mizutani, M., Cardona, S. M., Charo, I. F., Ransohoff, R. M., Forsthuber, T. G., & Cardona, A. E. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1300040 · Cited by 87
“Free-floating 30-mm sections were prepared using a freezing microtome and stored at 220 ̊C until use (2).”
BackgroundMethodSelf-citationAdvances in transcriptome analysis of human brain aging
Ham, S., & Lee, S.-J. V. (2020) · Experimental & Molecular Medicine · doi:10.1038/s12276-020-00522-6 · Cited by 84
Umekawa, T., Osman, A. M., Han, W., Ikeda, T., & Blomgren, K. (2015) · Glia · doi:10.1002/glia.22887 · Cited by 86
“Moreover, we showed that Cx3cr1-GFP1 and Ccr2-RFP1 cells overlapped completely with Iba1, a marker expressed in both resident microglia and blood-derived macrophages, as reported previously (Cardona et al., 2006).”
ResultValdeolivas, S., Pazos, M. R., Bisogno, T., Piscitelli, F., Iannotti, F. A., Allarà, M., Sagredo, O., Di Marzo, V, & Fernández-Ruiz, J. (2013) · Cell Death & Disease · doi:10.1038/cddis.2013.387 · Cited by 87
“investigation, it was evident that astrocytes underwent morphological alterations after the lesion, similar to those previously reported.(29) Such alterations were notably reduced”
ResultMcComb, J. G., Ranganathan, M., Liu, X. H., Pilewski, J. M., Ray, P., Watkins, S. C., Choi, A. M. K., & Lee, J. S. (2008) · The American Journal of Pathology · doi:10.2353/ajpath.2008.071034 · Cited by 86
Self-citationCan we switch microglia's phenotype to foster neuroprotection? Focus on multiple sclerosis
Giunti, D., Parodi, B., Cordano, C., Uccelli, A., & Kerlero de Rosbo, N. (2014) · Immunology · doi:10.1111/imm.12177 · Cited by 85
Rod-shaped microglia morphology is associated with aging in 2 human autopsy series
Bachstetter, A. D., Ighodaro, E. T., Hassoun, Y., Aldeiri, D., Neltner, J. H., Patel, E., Abner, E. L., & Nelson, P. T. (2017) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.12.028 · Cited by 84
“Yet, rod-shaped microglia are not a defining feature in CX3CR1 KO mice (Cardona et al., 2006, Rogers et al., 2011), so it is unlikely that this pathway is a sole driver for the formation of rod-shaped microglia.”
BackgroundMicroglial Activation After Systemic Stimulation With Lipopolysaccharide and Escherichia coli
Hoogland, I. C. M., Westhoff, D., Engelen-Lee, J.-Y., Melief, J., Serón, M. V., Houben-Weerts, J. H. P. M., Huitinga, I., van Westerloo, D. J., van der Poll, T., van Gool, W. A., et al. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00110 · Cited by 98
“…mechanisms on microglial cells are the cholinergic anti-inflammatory pathway (Shytle et al., 2004), fractalkine (CX3CL1) and its receptor (CX3CR1) (Cardona et al., 2006), cluster of differentiation 200 (CD200) and its receptor (CD200R) (Hoek et al., 2000), and cluster of differentiation 47 (CD47)…”
BackgroundChen, X., Jiang, M., Li, H., Wang, Y., Shen, H., Li, X., Zhang, Y., Wu, J., Yu, Z., & Chen, G. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-01882-6 · Cited by 85
“Additionally, the lacking of CX3CR1 was cytotoxic in models of amyotrophic lateral sclerosis, Parkinson’s disease, and Alzheimer’s disease [56, 57].”
Sheehan, J. J., Zhou, C., Gravanis, I., Rogove, A. D., Wu, Y., Bogenhagen, D. F., & Tsirka, S. E. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.4987-06.2007 · Cited by 93
“…in axon growth of injured retina ganglion cells (Filbin, 2006; Yin et al., 2006); however, microglia have been demonstrated to be toxic in multiple disease models (Block et al., 2006; Cardona et al., 2006; Lai and Todd, 2006), including our own studies of excitotoxicity (Rogove and Tsirka, 1998).”
BackgroundCognitive and Behavioral Consequences of Impaired Immunoregulation in Aging
Corona, A. W., Fenn, A. M., & Godbout, J. P. (2011) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-011-9313-4 · Cited by 94
“microglial-mediated neurotoxicity (Cardona et al. 2006).”
BackgroundThe Evolving Biology of Microglia in Alzheimer's Disease
Malm, T. M., Jay, T. R., & Landreth, G. E. (2015) · Neurotherapeutics · doi:10.1007/s13311-014-0316-8 · Cited by 85
“[94] showed that deficiency in CX3CR1 caused increased microglial activation and neurotoxicity in multiple neuroinflammatory contexts.”
BackgroundHypoxia promotes tau hyperphosphorylation with associated neuropathology in vascular dysfunction
Raz, L., Bhaskar, K., Weaver, J., Marini, S., Zhang, Q., Thompson, J. F., Espinoza, C., Iqbal, S., Maphis, N. M., Weston, L., et al. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2018.07.009 · Cited by 84
“We next explored evidence for inflammation by labeling microglia with an antibody that is a specific microglial marker, CX3CR1 (fractalkine receptor) [37].”
Cunha, C., Santos, C., Gomes, C., Fernandes, A. M. A., Correia, A. M., Sebastião, A. M., Vaz, A. R., & Brites, D. M. T. O. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0631-2 · Cited by 93
Maggi, L., Trettel, F., Scianni, M., Bertollini, C., Eusebi, F., Fredholm, B. B., & Limatola, C. (2009) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2009.07.016 · Cited by 90
“Since both CX3CR1 and A3R may be more abundant on microglial cells than on neurons (Jung et al., 2000; Cardona et al., 2006; Hammarberg et al., 2003) whereas LTP is mainly a neuronal phenomenon, it is possible that the effect here described involves crosstalk between cells and that other mediator(s) might contribute.”
BackgroundInfluentialDinel, A., André, C., Aubert, A., Ferreira, G., Layé, S., & Castanon, N. (2013) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2013.10.014 · Cited by 94
“, 2010), which normally allows neurons to control microglial activation (Cardona et al., 2006).”
BackgroundResultPathological differences between white and grey matter multiple sclerosis lesions
Prins, M., Schul, E., Geurts, J., van der Valk, P., Drukarch, B., & van Dam, A. (2015) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12841 · Cited by 84
Simon, E., Obst, J., & Gomez-Nicola, D. (2019) · Neuroscience · doi:10.1016/j.neuroscience.2018.01.059 · Cited by 83
Age exacerbates the CCR2/5-mediated neuroinflammatory response to traumatic brain injury
Morganti, J. M., Riparip, L.-K., Chou, A., Liu, S., Gupta, N., & Rosi, S. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0547-1 · Cited by 82
“sponses [19, 20].”
Ishizuka, K., Fujita, Y., Kawabata, T., Kimura, H., Iwayama, Y., Inada, T., Okahisa, Y., Egawa, J., Usami, M., Kushima, I., et al. (2017) · Translational Psychiatry · doi:10.1038/tp.2017.173 · Cited by 83
Borkum, J. M. (2017) · Headache The Journal of Head and Face Pain · doi:10.1111/head.13214 · Cited by 89
Zanier, E. R., Marchesi, F., Ortolano, F., Perego, C., Arabian, M., Zoerle, T., Sammali, E., Pischiutta, F., & De Simoni, M.-G. (2016) · Journal of Neurotrauma · doi:10.1089/neu.2015.4041 · Cited by 94
“We report that the loss of CX3CL1:CX3CR1 interaction is associated with a different neuroinflammatory response in TBI, mediated by M/l.”
BackgroundInfluentialReshef, R., Kreisel, T., Kay, D. B., & Yirmiya, R. (2014) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2014.04.009 · Cited by 87
“Signaling via the microglial CX3CR1 constitutes an important regulatory mechanism, by which neuronally-derived CX3CL1 (fractalkine) restrains microglial over-activation during various inflammatory conditions (Biber et al., 2007; Cardona et al., 2006; Harrison et al., 1998; Ransohoff et al., 2007; Wolf et al., 2013).”
Molecular subtypes of ALS are associated with differences in patient prognosis
Eshima, J., O’Connor, S. A., Marschall, E., NYGC ALS Consortium, Bowser, R., Plaisier, C. L., & Smith, B. S. (2023) · Nature Communications · doi:10.1038/s41467-022-35494-w · Cited by 79
Ferretti, E., Pistoia, V., & Corcione, A. (2014) · Mediators of Inflammation · doi:10.1155/2014/480941 · Cited by 82
“High CX3CL1 levels correlate with the progression and severity of the disease as demonstrated in CX3CL1 or CX3CR1 deficient mice which show an increased brain neurodegeneration [58, 59].”
BackgroundShan, S., Hong-Min, T., Yi, F., Jun-Peng, G., Yue, F. L., Yan-hong, T., Yun-ke, Y., Li, W., Wang, X., Ma, J., et al. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.03.004 · Cited by 94
De Haas, A. H., Boddeke, H. W. G. M., Brouwer, N., & Biber, K. (2007) · Glia · doi:10.1002/glia.20554 · Cited by 81
“…prominent neuroprotective activity as well, suggesting a balance between neurotoxic and neuroprotective microglia activity (Bailey et al., 2006; Cardona et al., 2006; Kempermann and Neumann, 2003; Kim and de Vellis, 2005; LalancetteHebert et al., 2007; Li et al., 2006; Nakajima and Kohsaka,…”
BackgroundFractalkine receptor regulates microglial neurotoxicity in an experimental mouse glaucoma model
Wang, K., Peng, B., & Lin, B. (2014) · Glia · doi:10.1002/glia.22715 · Cited by 81
“To investigate the potential contribution of the Cx3cr1 pathway to retinal microglia activation in glaucoma, we took advantage of transgenic mice in which the Cx3cr1 gene was replaced with a cDNA encoding green fluorescent protein (GFP) on both alleles (Cardona et al., 2006; Jung et al., 2000), and created experimenta…”
BackgroundResultInfluentialGlial Modulators as Potential Treatments of Psychostimulant Abuse
Beardsley, P. M., & Hauser, K. F. (2014) · Advances in Pharmacology · doi:10.1016/b978-0-12-420118-7.00001-9 · Cited by 81
Neurogenesis in the chronic lesions of multiple sclerosis
Chang, A., Smith, M. C., Yin, X., Fox, R. J., Staugaitis, S. M., & Trapp, B. D. (2008) · Brain · doi:10.1093/brain/awn157 · Cited by 85
“Indeed, the inflammatory microenvironment contains a variety of substances that could potentially injure neurons, including proteolytic enzymes, cytokines, oxidative products and free radicals produced by activated immune and glial cells (Thery et al., 1991; Chao et al., 1992; Giulian et al., 1993; Moore and Thanos, 1…”
Barrientos, R. M., Frank, M. G., Watkins, L. R., & Maier, S. F. (2012) · Hormones and Behavior · doi:10.1016/j.yhbeh.2012.02.010 · Cited by 92
“Likewise, young mice deficient in the microglial fractalkine receptor (CX3CR1−/−) demonstrated long-lasting microglial activation (Corona et al., 2010) and neurotoxicity (Cardona et al., 2006) in response to a Horm Behav.”
BackgroundDecreased Fractalkine and Increased IP-10 Expression in Aged Brain of APPswe Transgenic Mice
Duan, R., Yang, X., Chen, Z., Lu, M., Morris, C. M., Winblad, B. G., & Zhu, J. (2007) · Neurochemical Research · doi:10.1007/s11064-007-9554-z · Cited by 86
“well [9], both in vitro [10] and in vivo [11].”
BackgroundCardona, S. M., Mendiola, A. S., Yang, Y.-C., Adkins, S. L., Torres, V., & Cardona, A. E. (2015) · ASN Neuro · doi:10.1177/1759091415608204 · Cited by 81
Self-citationBoxer, A. L., Gold, M., Huey, E., Gao, F., Burton, E. A., Chow, T., Kao, A., Leavitt, B. R., Lamb, B., Grether, M., et al. (2013) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2012.03.002 · Cited by 80
Sárvári, M., Hrabovszky, E., Kalló, I., Solymosi, N., Tóth, K., Likó, I., Széles, J., Mahó, S., Molnár, B., & Liposits, Z. (2011) · Journal of Neuroinflammation · doi:10.1186/1742-2094-8-82 · Cited by 78
“involved in the regulation of microglia neurotoxicity [56], E2 may alter this microglia function via down-regulation of Cx3cr1.”
BackgroundPhysical Exercise-Induced Myokines in Neurodegenerative Diseases
Lee, B., Shin, M., Park, Y., Won, S.-Y., & Cho, K. S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115795 · Cited by 79
“G-proteincoupled receptor C-X3-C Motif Chemokine Receptor 1 (CX3CR1) has been identified as the receptor for CX3CL1 and implicated in the function of leukocytes and microglia [115,116].”
BackgroundLowery, R. L., Tremblay, M.-E., Hopkins, B. E., & Majewska, A. K. (2017) · Glia · doi:10.1002/glia.23192 · Cited by 79
“The chemokine fractalkine is known to alter microglial behavior in pathological conditions (Bisht et al., 2016; Cardona et al., 2006; Seo et al., 2016; Wang, Peng, & Lin, 2014; Zabel et al., 2016; Zujovic, Benavides, Vige, Carter, & Taupin, 2000), but could similarly serve physiological roles.”
BackgroundInfluentialZhang, M., Xu, G., Liu, W., Ni, Y., & Zhou, W. (2012) · PLoS ONE · doi:10.1371/journal.pone.0035446 · Cited by 79
“On the other hand, loss of CX3CR1 exaggerates neuron apoptosis in Parkinson’s disease [27], amyotrophic lateral sclerosis [27], and encephalomyelitis [44].”
Microglia as a critical player in both developmental and late-life CNS pathologies
Derecki, N. C., Katzmarski, N., Kipnis, J., & Meyer-Luehmann, M. (2014) · Acta Neuropathologica · doi:10.1007/s00401-014-1321-z · Cited by 78
“Fractalkine is another such modulatory molecule produced by neural cells, suggested to act directly on the microglial CX3CR1 receptor to prevent neurotoxicity [19, 71].”
BackgroundHerbal Medicines for Ischemic Stroke: Combating Inflammation as Therapeutic Targets
Gu, Y., Chen, J., & Shen, J. (2014) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-014-9525-5 · Cited by 86
Relationship Between Obesity, Alzheimer’s Disease, and Parkinson’s Disease: an Astrocentric View
Martín-Jiménez, C., Gaitán-Vaca, D. M., Echeverría, V., González, J., & Barreto, G. E. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-0193-8 · Cited by 82
Microglia Express Mu Opioid Receptor: Insights From Transcriptomics and Fluorescent Reporter Mice
Maduna, T., Audouard, E., Dembélé, D., Mouzaoui, N., Reiss, D. J., Massotte, D., & Gavériaux‐Ruff, C. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2018.00726 · Cited by 79
“MOR Expression in CX3cr1-eGFP Microglia MOR Expression in Brain and Spinal Cord The Figures 10, 11 show that Cx3cr1-eGFP-positive cells display the typical microglia morphology with no neuronal, astrocytic or lymphocytic shapes, confirming previous findings on colocalization of CX3CR1-eGFP with the CD11b or Iba1 micro…”
ResultSato, E., Shick, H. E., Ransohoff, R. M., & Hirose, K. (2007) · The Journal of Comparative Neurology · doi:10.1002/cne.21583 · Cited by 84
“Studies have recently shown that the deletion of CX3CR1 in mice causes increased microglial neurotoxicity in three disease models: lipopolysaccharide-induced neuroinflammation, MPTP neurotoxicity, and the SOD transgenic model of amyotrophic lateral sclerosis (Cardona et al., 2006).”
BackgroundSelf-citationAn engineered CX3CR1 antagonist endowed with anti-inflammatory activity
Dorgham, K., Ghadiri, A., Hermand, P., Rodero, M., Poupel, L., Iga, M., Hartley, O., Gorochov, G., Combadière, C., & Deterre, P. (2009) · Journal of Leukocyte Biology · doi:10.1189/jlb.0308158 · Cited by 78
“The genetic ablation of mCX3CR1 leads to decreased atherogenesis but to increased brain inflammation and pain facilitation [10– 13], to increased microglial neurotoxicity [14], and to early AMD [15].”
BackgroundMyeloid cell responses after spinal cord injury
David, S., Kroner, A., Greenhalgh, A. D., Zarruk, J. G., & López-Vales, R. (2018) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2018.06.003 · Cited by 77
Emerging roles of microglial cathepsins in neurodegenerative disease
Lowry, J. R., & Klegeris, A. (2018) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2018.02.014 · Cited by 86
Anwar, S., & Rivest, S. (2020) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2020.1738391 · Cited by 77
“cent protein (GFP) reporter gene that leads to systemic inflammation and exacerbated microglial neurotoxicity in a variety of animal models of neurodegenerative diseases [131].”
BackgroundInflammation in the pathogenesis of depression: a disorder of neuroimmune origin
Corrigan, M., O’Rourke, A. M., Moran, B., Fletcher, J. M., & Harkin, A. (2023) · Neuronal Signaling · doi:10.1042/ns20220054 · Cited by 86
“Cardona et al. (2006) showed that CX3CR1-deficient mice were more vulnerable to neuronal loss following systemic LPS injection compared to wildtype [13].”
Fractalkine is a “find-me†signal released by neurons undergoing ethanol-induced apoptosis
Sokolowski, J. D., Chabanon-Hicks, C. N., Han, C. Z., Heffron, D. S., & Mandell, J. W. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00360 · Cited by 77
“…signaling promotes a beneficial versus a detrimental response has been unclear, as studies have come to different conclusions depending on the injury model and the outcomes measured (Mizuno et al., 2003; Cardona et al., 2006; Fuller and Van Eldik, 2008; Staniland et al., 2010; Noda et al., 2011).”
ResultAccumulation of murine subretinal macrophages: effects of age, pigmentation and CX3CR1
Chinnery, H. R., McLenachan, S., Humphries, T. G., Kezic, J. M., Chen, X., Ruitenberg, M. J., & McMenamin, P. G. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.03.010 · Cited by 84
“…of these functions are poorly understood, however, signaling via the CX3CL1 (fractalkine) (Bazan et al., 1997) eceptor, CX3CR1, is thought to play a central role, because its absence results in microglia adopting a neurotoxic phenotype upon activation (Block et al., 2007; Cardona et al., 2006).”
BackgroundRole of Microglial Activation in the Pathophysiology of Bacterial Meningitis
Barichello, T., Generoso, J. S., Simões, L. R., Goularte, J. A., Petronilho, F. C., Saigal, P., Badawy, M., & Quevedo, J. (2015) · Molecular Neurobiology · doi:10.1007/s12035-015-9107-4 · Cited by 83
“CX3CL1 knockout mice had microglial activation in different models of brain disease, including toxic insult by peripheral LPS injections [106].”
MethodHernangomez, M., Carrillo-Salinas, F., Mecha, M., Correa, F., Mestre, L., Loria, F., Feliu, A., Docagne, F., & Guaza, C. (2014) · Current Pharmaceutical Design · doi:10.2174/1381612820666140130202911 · Cited by 77
“Another NIReg with a potential critical role in neuroprotection include the pair neuronal CX3CL1 and microglial CX3CR1 [57].”
The Neuroinflammatory Response in ALS: The Roles of Microglia and T Cells
Lewis, C.-A., Manning, J., Rossi, F., & Krieger, C. (2012) · Neurology Research International · doi:10.1155/2012/803701 · Cited by 76
“CX3CR1−/− mice exhibit dysregulated microglial responses following peripheral injection of LPS, while CX3CR1 ablation in mSOD mice results in increased levels of neuronal loss [19].”
BackgroundMachado, V., Zöller, T., Attaai, A., & Spittau, B. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17020151 · Cited by 76
“Cardona and colleagues [59] reported a higher loss of Th- and Nissl-positive cells both in Cx3cl1 ́{ ́ and Cx3cr1 ́{ ́ mice.”
BackgroundRodero, M. P., Marie, Y., Coudert, M., Blondet, E., Mokhtari, K., Rousseau, A., Raoul, W., Carpentier, C., Sennlaub, F., Déterre, P., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.17.2833 · Cited by 88
Microglia can be induced by IFN-γ or IL-4 to express neural or dendritic-like markers
Butovsky, O., Bukshpan, S., Kunis, G., Jung, S., & Schwartz, M. (2007) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2007.04.009 · Cited by 90
Self-citationHelp-me signaling: Non-cell autonomous mechanisms of neuroprotection and neurorecovery
Xing, C., & Lo, E. H. (2017) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2016.04.004 · Cited by 76
“Beyond ischemia and excitotoxicity per se, beneficial effects of CX3CL1 have also been documented in other injury conditions such as 6-hydroxydopamine (6-OHDA) or MPTP models of Parkinson’s disease (Cardona et al., 2006; Pabon et al., 2011).”
Influentiall‐DOPA‐induced dyskinesia and neuroinflammation: do microglia and astrocytes play a role?
Carta, A. R., Mulas, G., Bortolanza, M., Duarte, T., Pillai, E., Fisone, G., Vozari, R. R., & Del‐Bel, E. (2017) · European Journal of Neuroscience · doi:10.1111/ejn.13482 · Cited by 75
“As mentioned above, the CX3CR1/ CX3CL1 signaling holds a pivotal role in the neuron-microglia communication in the healthy brain.”
BackgroundInfluentialMice deficient in NRROS show abnormal microglial development and neurological disorders
Wong, K., Noubade, R., Manzanillo, P., Ota, N., Foreman, O., Hackney, J. A., Friedman, B. A., Pappu, R., Scearce-Levie, K., & Ouyang, W. (2017) · Nature Immunology · doi:10.1038/ni.3743 · Cited by 71
Changes in Retinal Glial Cells with Age and during Development of Age-Related Macular Degeneration
Telegina, D. V., Kozhevnikova, O. S., & Kolosova, N. G. (2018) · Biochemistry (Moscow) · doi:10.1134/s000629791809002x · Cited by 75
Interaction of microglia with infiltrating immune cells in the different phases of stroke
Berchtold, D., Priller, J., Meisel, C., & Meisel, A. (2020) · Brain Pathology · doi:10.1111/bpa.12911 · Cited by 88
“It is hypothesized that depending on the context (ie, homeostatic brain or inflamed CNS containing infiltrating myeloid cells possibly also expressing CX3CR1), the CX3CR1-CX3CL1 axis could have different effects on microglia/macrophage activation and brain inflammation (12).”
BackgroundThe biology of chemokines and their receptors
Lira, S. A., & Furtado, G. C. (2012) · Immunologic Research · doi:10.1007/s12026-012-8313-7 · Cited by 76
“In collaboration with Richard Ransohoff’s group, we have shown that Cx3cr1 deficiency dysregulates microglial responses, resulting in neurotoxicity [24].”
BackgroundSelf-citationZimmermann, J., Krauthausen, M., Hofer, M. J., Heneka, M. T., Campbell, I. L., & Müller, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0057307 · Cited by 75
“To address this question, we subjected GF/IL17 mice and wild-type littermates to a peripheral immune challenge by intraperitoneal injections of LPS, a model inducing a neuroinflammatory response [69–71].”
MethodInnate immune activation in Alzheimer’s disease
Wang, M.-M., Miao, D., Cao, X.-P., Tan, L., & Tan, L. (2018) · Annals of Translational Medicine · doi:10.21037/atm.2018.04.20 · Cited by 72
Rod microglia and their role in neurological diseases
Holloway, O. G., Canty, A. J., King, A. E., & Ziebell, J. M. (2019) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2019.02.005 · Cited by 86
CX3CR1 Is a Modifying Gene of Survival and Progression in Amyotrophic Lateral Sclerosis
Lopez-Lopez, A., Gamez, J., Syriani, E., Morales, M., Salvado, M., Rodríguez, M. J., Mahy, N., & Vidal-Taboada, J. M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0096528 · Cited by 74
“The CX3CR1 gene (chemokine (C-X3-C motif) receptor 1, also known as Fractalkine receptor, OMIM: 601470) in the brain is only expressed by microglia [20] and it has been proposed as a key mediator of neuron-microglia interactions that is upregulated in many inflammatory conditions [21,22].”
Microglial calcium signaling in the adult, aged and diseased brain
Brawek, B., & Garaschuk, O. (2013) · Cell Calcium · doi:10.1016/j.ceca.2012.12.003 · Cited by 78
“In contrast, fractalkineediated communication between neurons and microglia has been hown to be neuroprotective in mouse models of amyotrophic ateral sclerosis and PD [37].”
InfluentialDeng, Y.-H., He, H.-Y., Ren, L., & Guo, T. (2019) · Neural Regeneration Research · doi:10.4103/1673-5374.244793 · Cited by 69
“Ultimately, microglial inflammation is excessively activated and may worsen brain damage (Cardona et al., 2006).”
BackgroundInfluentialPentón-Rol, G., Marín-Prida, J., & McCarty, M. F. (2021) · Current Neuropharmacology · doi:10.2174/1570159x19666210408123807 · Cited by 73
“Both Sp extract and C-PC were able to promote the survival of microglial cells in culture subjected to lipopolysaccharide toxicity, and to reduce the mRNA levels of inducible nitric oxide synthase (iNOS), cyclooxygenase-2 (COX-2), TNF-α, and IL-6 in these cells [118].”
InfluentialHao, J., Campagnolo, D. I., Liu, R., Piao, W., Shi, S. X.-Y., Hu, B., Xiang, R., Zhou, Q., Vollmer, T. L., Kaer, L. V., et al. (2010) · Annals of Neurology · doi:10.1002/ana.22339 · Cited by 81
Neuro-immune dysfunction during brain aging: new insights in microglial cell regulation
Matt, S. M., & Johnson, R. W. (2016) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2015.10.009 · Cited by 73
“Aging is associated with reduced signaling of both of these pairs [34,35], and mice deficient in either CD200 or CX3CR1 exhibit an activated microglial phenotype [36,37].”
BackgroundInflammatory Responses are Sex Specific in Chronic Hypoxic–Ischemic Encephalopathy
Mamun, A. A., Yu, H., Sharmeen, R., & Liu, F. (2018) · Cell Transplantation · doi:10.1177/0963689718766362 · Cited by 83
Kaur, T., Clayman, A. C., Nash, A. J., Schrader, A. D., Warchol, M. E., & Ohlemiller, K. K. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00620 · Cited by 72
Amyotrophic Lateral Sclerosis Survival Associates With Neutrophils in a Sex-specific Manner
Murdock, B. J., Goutman, S. A., Boss, J., Kim, S., & Feldman, E. L. (2021) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000000953 · Cited by 76
“For instance, 1 study examining the role of fractalkine receptor function in the microglia of ALS mice found that knockout of the receptor accelerated disease progression only in male mice.(41) Another study showed that axonal sprouting varies between male and female SOD1 mice.”
BackgroundBeyond the neuron: Role of non-neuronal cells in stress disorders
Cathomas, F., Holt, L. M., Parise, E. M., Liu, J., Murrough, J. W., Casaccia, P., Nestler, E. J., & Russo, S. J. (2022) · Neuron · doi:10.1016/j.neuron.2022.01.033 · Cited by 76
Microglia in Ischemic Stroke: Pathogenesis Insights and Therapeutic Challenges
Shui, X., Chen, J., Fu, Z., Zhu, H., Tao, H., & Li, Z. (2024) · Journal of Inflammation Research · doi:10.2147/jir.s461795 · Cited by 85
“193 Furthermore, the collaboration between microglia and astrocytes is thought to be a part of the process of forming a glial scar after stroke.”
BackgroundLobsiger, C. S., Boillée, S., Pozniak, C., Khan, A. M., McAlonis-Downes, M., Lewcock, J. W., & Cleveland, D. W. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1318309110 · Cited by 72
“In a recent study assessing the role of the neuroinflammation-related chemokine receptor CX3CR1 (the fraktalkine receptor), gene deletion (of Cx3cr1) was reported to very modestly change disease course, but only in male mutant SOD1 mice (55).”
BackgroundStress-induced neuroinflammatory priming is time of day dependent
Fonken, L. K., Weber, M. D., Daut, R. A., Kitt, M. M., Frank, M. G., Watkins, L. R., & Maier, S. F. (2016) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2016.01.006 · Cited by 79
Yoshino, Y., Roy, B., & Dwivedi, Y. (2021) · Neuropsychopharmacology · doi:10.1038/s41386-020-00861-y · Cited by 70
Microglial Activation and Oxidative Stress in PM2.5-Induced Neurodegenerative Disorders
Song, J., Han, K., Wang, Y., Qu, R., Liu, Y., Wang, S., Wang, Y., An, Z., Li, J., Wu, H., et al. (2022) · Antioxidants · doi:10.3390/antiox11081482 · Cited by 90
Early morphofunctional plasticity of microglia in response to acute lipopolysaccharide
Madore, C., Joffre, C., Delpech, J.-C., Smedt, V. D., Aubert, A., Coste, L., Layé, S., & Nadjar, A. (2013) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2013.08.008 · Cited by 79
“Several groups have reported that this microglia isolation procedure yields a highly enriched population of microglia (Cardona et al., 2006; Frank et al., 2006; Henry et al., 2009).”
BackgroundErreni, M., Solinas, G., Brescia, P., Osti, D., Zunino, F., Colombo, P., Destro, A., Roncalli, M. G., Mantovani, A., Draghi, R., et al. (2010) · European Journal of Cancer · doi:10.1016/j.ejca.2010.07.022 · Cited by 78
CX3CR1 deficiency promotes muscle repair and regeneration by enhancing macrophage ApoE production
Arnold, L., Perrin, H., de Chanville, C. B., Saclier, M., Hermand, P., Poupel, L., Guyon, E., Licata, F., Carpentier, W., Vilar, J., et al. (2015) · Nature Communications · doi:10.1038/ncomms9972 · Cited by 71
Lam, D., Lively, S., & Schlichter, L. C. (2017) · Journal of Neuroinflammation · doi:10.1186/s12974-017-0941-3 · Cited by 71
“CX3CR1-null mice are said to display microglial hyper-activation [84] but its role is apparently damage-dependent because CX3CR1 deletion was beneficial in models of transient ischemia [85] and Alzheimer’s [86] but harmful in Parkinson’s and ALS models [87].”
Sanberg, P. R., Eve, D. J., Willing, A. E., Garbuzova-Davis, S. N., Tan, J., Sanberg, C. D., Allickson, J. G., Cruz, L. E. G., & Borlongan, C. V. (2010) · Cell Transplantation · doi:10.3727/096368910x532855 · Cited by 76
Microglia Receptors in Animal Models of Traumatic Brain Injury
Younger, D., Murugan, M., Rao, K. V. R., Wu, L., & Chandra, N. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-1428-7 · Cited by 73
Hrelia, P., Sita, G., Ziche, M., Ristori, E., Marino, A., Cordaro, M., Molteni, R., Spero, V., Malaguti, M., Morroni, F., et al. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/8363245 · Cited by 75
“Furthermore, aged microglia cells adopt a proinflammatory state due to a decrease in the resting signalling by neurons and astrocytes [143].”
Background
Metadata
- Authors
- Cardona, A. E., Pioro, E. P., Sasse, M. E., Kostenko, V., Cardona, S. M., Dijkstra, I. M., Huang, D., Kidd, G., Dombrowski, S., Dutta, R., Lee, J.-C., Cook, D. N., Jung, S., Lira, S. A., Littman, D. R., & Ransohoff, R. M.
- Affiliations
- Cleveland Clinic (US)
- National Institute of Environmental Health Sciences (US)
- Howard Hughes Medical Institute (US)
- Corresponding author
- Ransohoff, Richard M
- ORCID
- Venue
- Nature Neuroscience
- Published
- 2006-06-18
- Volume
- 9
- Issue
- 7
- Pages
- 917-924
- ISSN
- 1097-6256 (ISSN-L)
- 1546-1726
- OpenAlex
- W2113107925
- Cited by
- 1,531
- References
- 39
- Citations by year
- 2026: 46 · 2025: 44 · 2024: 84 · 2023: 62 · 2022: 83 · 2021: 73 · 2020: 66 · 2019: 76 · 2018: 95 · 2017: 90 · 2016: 87 · 2015: 102 · 2014: 133 · 2013: 104 · 2012: 90
- FWCI
- 32.69
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Neurological Disorders and Stroke (NS32151, R01NS032151)
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- microglia, CX3CR1, microglial neurotoxicity, neuroinflammation, lipopolysaccharide, Parkinson's disease, amyotrophic lateral sclerosis, neuronal loss, CX3CR1 knockout mice
- MeSH terms
- CX3C Chemokine Receptor 1, Analysis of Variance, Animals, Calcium-Binding Proteins, Cells, Cultured, Central Nervous System, Disease Models, Animal, Flow Cytometry, Immunohistochemistry, Lipopolysaccharides, Mice, Inbred C57BL, Mice, Transgenic, Microfilament Proteins, Nerve Tissue Proteins, Neurons, Parkinson Disease, Cytokines, Motor Neuron Disease, Cell Death, Microglia, Receptors, Chemokine, Neurotoxicity Syndromes, Green Fluorescent Proteins, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.